Anti-Hypertensive Agent (ACEi) and Heart Function Improvement in Association With Rho Kinase Activity Changes in Human
- First Posted Date
- 2010-02-17
- Last Posted Date
- 2010-02-25
- Lead Sponsor
- National Cheng-Kung University Hospital
- Target Recruit Count
- 60
- Registration Number
- NCT01069042
- Locations
- π¨π³
National Cheng Kung University Hospital, Tainan, Taiwan
Comparison of the Efficacy and Safety Between Pioglitazone and Placebo Added to Combination Therapy in Type 2 Diabetes
- First Posted Date
- 2009-10-07
- Last Posted Date
- 2009-10-07
- Lead Sponsor
- National Cheng-Kung University Hospital
- Target Recruit Count
- 40
- Registration Number
- NCT00991055
- Locations
- π¨π³
National Cheng Kung University Hospital, Tainan, Taiwan
Tailored Second Line Treatment by Epidermal Growth Factor Receptor (EGFR) Mutation in Patients With Advanced Lung Adenocarcinoma
Not Applicable
- Conditions
- Non-Small Cell Lung Cancer
- Interventions
- First Posted Date
- 2009-05-18
- Last Posted Date
- 2009-05-18
- Lead Sponsor
- National Cheng-Kung University Hospital
- Target Recruit Count
- 52
- Registration Number
- NCT00903292
- Locations
- π¨π³
National Cheng-Kung University Hospital, Tainan, Taiwan
Thalidomide and Tegafur/Uracil(UFUR) in the Treatment of Advanced Colorectal Cancer
- First Posted Date
- 2009-04-29
- Last Posted Date
- 2009-05-07
- Lead Sponsor
- National Cheng-Kung University Hospital
- Target Recruit Count
- 34
- Registration Number
- NCT00890188
- Locations
- π¨π³
National Cheng-Kung University Hospital, Tainan, Taiwan
Patient-Ventilator Dyssynchrony: How is the Effect of Management?
- Conditions
- Respiratory Failure
- First Posted Date
- 2008-05-23
- Last Posted Date
- 2008-05-23
- Lead Sponsor
- National Cheng-Kung University Hospital
- Target Recruit Count
- 40
- Registration Number
- NCT00683072
- Locations
- π¨π³
National Cheng-Kung University Hospital, Tainan, Taiwan
Vascular Endothelial Protection Effects of Dextromethorphan
- First Posted Date
- 2008-01-31
- Last Posted Date
- 2008-01-31
- Lead Sponsor
- National Cheng-Kung University Hospital
- Target Recruit Count
- 40
- Registration Number
- NCT00605605
- Locations
- π¨π³
National Cheng Kung University Hospital, Tainan, Taiwan
Vascular Effects of Ezetimibe/Simvastatin and Simvastatin on Atherosclerosis
Phase 4
Completed
- Conditions
- Atherosclerosis
- Interventions
- Drug: 10mg/10mg of Ezetimibe/Simvastatin (Vytorin)
- First Posted Date
- 2007-11-19
- Last Posted Date
- 2010-02-24
- Lead Sponsor
- National Cheng-Kung University Hospital
- Target Recruit Count
- 40
- Registration Number
- NCT00560170
- Locations
- π¨π³
National Cheng Kung University Hospital, Tainan, Taiwan
Genetic Studies Spermatogenic Failure
Completed
- Conditions
- AzoospermiaOligospermiaMale Infertility
- First Posted Date
- 2007-10-25
- Last Posted Date
- 2007-10-25
- Lead Sponsor
- National Cheng-Kung University Hospital
- Target Recruit Count
- 283
- Registration Number
- NCT00548977
- Locations
- π¨π³
National Cheng-Kung University Hospital, Tainan, Taiwan
Multiple Grain in Type 2 Diabetes
Phase 4
- Conditions
- Diabetes Mellitus
- First Posted Date
- 2006-06-15
- Last Posted Date
- 2006-10-18
- Lead Sponsor
- National Cheng-Kung University Hospital
- Target Recruit Count
- 30
- Registration Number
- NCT00337337
- Locations
- π¨π³
National Cheng-Kung University Hospital, Tainan, Taiwan
A Double-Blind, Randomized, Parallel, Comparative Study to Evaluate the Efficacy and Safety of an Antidiabetic Agent Repaglinide for the Treatment of Type 2 Diabetes Mellitus Patients
Phase 4
- Conditions
- Diabetes Mellitus, Type 2
- First Posted Date
- 2006-06-13
- Last Posted Date
- 2006-06-13
- Lead Sponsor
- National Cheng-Kung University Hospital
- Target Recruit Count
- 50
- Registration Number
- NCT00336310
- Locations
- π¨π³
National Cheng-Kung University Hospital, Tainan, Taiwan
Β© Copyright 2025. All Rights Reserved by MedPath